- Home
- AUTL vs RWAY Comparison
AUTL vs RWAY Comparison
Compare AUTL & RWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- RWAY
- Stock Information
- Founded
- AUTL 2014
- RWAY 2015
- Country
- AUTL United Kingdom
- RWAY United States
- Employees
- AUTL N/A
- RWAY N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- RWAY
- Sector
- AUTL Health Care
- RWAY
- Exchange
- AUTL Nasdaq
- RWAY Nasdaq
- Market Cap
- AUTL 359.3M
- RWAY 395.5M
- IPO Year
- AUTL 2018
- RWAY 2021
- Fundamental
- Price
- AUTL $1.27
- RWAY $10.04
- Analyst Decision
- AUTL Strong Buy
- RWAY Buy
- Analyst Count
- AUTL 5
- RWAY 7
- Target Price
- AUTL $9.32
- RWAY $11.07
- AVG Volume (30 Days)
- AUTL 2.4M
- RWAY 308.7K
- Earning Date
- AUTL 05-08-2025
- RWAY 05-12-2025
- Dividend Yield
- AUTL N/A
- RWAY 12.06%
- EPS Growth
- AUTL N/A
- RWAY 73.09
- EPS
- AUTL N/A
- RWAY 1.66
- Revenue
- AUTL $9,011,000.00
- RWAY $140,021,000.00
- Revenue This Year
- AUTL $277.74
- RWAY N/A
- Revenue Next Year
- AUTL $221.89
- RWAY $0.71
- P/E Ratio
- AUTL N/A
- RWAY $6.03
- Revenue Growth
- AUTL N/A
- RWAY N/A
- 52 Week Low
- AUTL $1.11
- RWAY $8.35
- 52 Week High
- AUTL $5.00
- RWAY $12.21
- Technical
- Relative Strength Index (RSI)
- AUTL 43.50
- RWAY 62.20
- Support Level
- AUTL $1.15
- RWAY $8.95
- Resistance Level
- AUTL $1.44
- RWAY $9.25
- Average True Range (ATR)
- AUTL 0.13
- RWAY 0.23
- MACD
- AUTL 0.01
- RWAY 0.13
- Stochastic Oscillator
- AUTL 29.27
- RWAY 83.33
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About RWAY Runway Growth Finance Corp.
Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and Canada, with the majority of its portfolio invested in the United States.